α-Blocker Use Is Associated With Decreased Risk of Sexual Dysfunction

Urology

Volumn 74, Issue 1, 2009, Pages 82-87

  Kumar, Rajeev ^a   Nehra, Ajay ^b   Jacobson, Debra J ^b   McGree, Michaela E ^b   Gades, Naomi M ^b   Lieber, Michael M ^b   Jacobsen, Steven J ^c   St Sauver, Jennifer L ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Mayo Clinic   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; DOXAZOSIN; PRAZOSIN; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; ARTICLE; CAUCASIAN; COHORT ANALYSIS; DISEASE SEVERITY; EJACULATION; EJACULATION DISORDER; ERECTILE DYSFUNCTION; FOLLOW UP; HUMAN; LIBIDO; LIBIDO DISORDER; LONGITUDINAL STUDY; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK REDUCTION; SEXUAL FUNCTION; SEXUAL SATISFACTION; SEXUALITY; UNITED STATES;

ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; HUMANS; MALE; MIDDLE AGED; PROSTATISM; RISK FACTORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 67649170448     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.12.080     Document Type: Article

References (16)

1. Braun M., Wassmer G., Klotz T., et al. Epidemiology of erectile dysfunction: results of the "Cologne Male Survey.". Int J Impot Res 12 (2000) 305-311
2. Rosen R., Altwein J., Boyle P., et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 44 (2003) 637-649
3. McVary K. Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology. BJU Int 97 suppl 2 (2006) 23-28
4. van Moorselaar R.J., Hartung R., Emberton M., et al., ALF-ONE Study Group. Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction. BJU Int 95 (2005) 603-608
5. Jacobsen S.J., Guess H.A., Panser L., et al. A population-based study of health care-seeking behavior for treatment of urinary symptoms: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med 2 (1993) 729-735
6. Oesterling J.E., Jacobsen S.J., Chute C.G., et al. Serum prostate-specific antigen in a community-based population of healthy men: establishment of age-specific reference ranges. JAMA 270 (1993) 860-864
7. O'Leary M.P., Rhodes T., Girman C.J., et al. Distribution of the brief male sexual inventory in community men. Int J Impot Res 15 (2003) 185-191
8. Burke J.P., Jacobson D.J., McGree M.E., et al. Diabetes and sexual dysfunction: results from the Olmsted County Study of Urinary Symptoms and Health Status Among Men. J Urol 177 (2007) 1438-1442
9. Barry M.J., Fowler Jr. F.J., O'Leary M.P., et al., Measurement Committee of the American Urological Association. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 148 (1992) 1558-1563
10. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika 67 (1980) 145-153
11. Costabile R.A., and Steers W.D. How can we best characterize the relationship between erectile dysfunction and benign prostatic hyperplasia?. J Sex Med 3 (2006) 676-681
12. Goldstein I. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. Int J Impot Res 12 suppl 1 (2000) S75-S80
13. Demir O., Murat N., Aslan G., et al. Effect of doxazosin with and without rho-kinase inhibitor on human corpus cavernosum smooth muscle in the presence of bladder outlet obstruction. J Urol 175 (2006) 22345-22349
14. Brookes S.T., Donovan J.L., and Peters T.J. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial. BMJ 324 (2002) 1059-1061
15. Kirby R.S., O'Leary M.P., and Carson C. Efficacy of extended-release doxazosin and doxazosin standard inpatients with concomitant benign prostatic hyperplasia and sexual dysfunction. BJU Int 95 (2005) 103-109
16. Höfner K., Claes H., De Reijke T.M., et al. Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. Eur Urol 36 (1999) 335-341